Lilly Slips as $6.5 Billion Plant Backs Oral GLP-1 Scale
Eli Lilly NYSE:LLY, the obesity and diabetes drugmaker, broke ground on a $6.5 billion Houston plant built to make ingredients for its Foundayo weight-loss pill and other medicines. Shares slipped about 0.8% to $1,160.91 Wednesday morning. That puts the stock 25.27% below its GF Value of roughly $1…